Article
Plasma Gamma-Glutamyltransferase Is Strongly Determined by Acylation Stimulating Protein…
Disease Markers · 2013 · Jumana Saleh, author Hatem Farhan, author Ibtisam Al-Saqri, author Bashair Al-Riyami, author Katherine Cianflone, author Vincent Sapin, Academic Editor
Key facts
| Title | Plasma Gamma-Glutamyltransferase Is Strongly Determined by Acylation Stimulating Protein Levels Independent of Insulin Resistance in Patients with Acute Coronary Syndrome |
|---|---|
| First author | Jumana Saleh, author Hatem Farhan, author Ibtisam Al-Saqri, author Bashair Al-Riyami, author Katherine Cianflone, author Vincent Sapin, Academic Editor |
| Journal | Disease Markers |
| Published | Jun 19, 2013 |
| DOI | 10.1155/2013/914748 |
| Devices mentioned | K000121, K000331, K000410, K000494, K000534, K000568, K000606, K001458, K003196, K003488, K003865, K010236 and 112 more |
| Product codes mentioned | CDQ, CDS, CDT, CEK, CEM, CEO, CFJ, CFN, CFR, CGA, CGS, CGX and 115 more |
At a glance
- 100–999 FDA submissions mentioned
- 100–999 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1